Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Multicentre, Open-label, Single-arm Study to Investigate the Efficacy, Safety and Durability of Faricimab (RO6867461) in Caucasian Patients With Polypoidal Choroidal Vasculopathy

NCT06709339 is registered in ClinicalTrials.gov with Association for Innovation and Biomedical Research on Light and Image as lead sponsor.

NCT NCT06709339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06709339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Multicentre, Open-label, Single-arm Study to Investigate the Efficacy, Safety and Durability of Faricimab (RO6867461) in Caucasian Patients With Polypoidal Choroidal Vasculopathy
Lead sponsor
Association for Innovation and Biomedical Research on Light and Image
Phase
Phase 4
Overall status
Recruiting
Start date
August 6, 2025
Completion date
August 31, 2028
Enrollment
120 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy